These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1972292)

  • 1. Antihypertensive treatment--effects on blood lipids: focus on beta-blockers.
    Olsson G
    Scand J Clin Lab Invest Suppl; 1990; 199():41-4. PubMed ID: 1972292
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of antihypertensive drugs on lipid metabolism.
    Leren P
    Clin Ther; 1987; 9(3):326-32. PubMed ID: 2886221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Physiotherapy in correction of proatherogenic shifts in long-term administration of beta-blockers and thiazide diuretics].
    Razumov AN; Kniazeva TA; Badtieva VA
    Vopr Kurortol Fizioter Lech Fiz Kult; 2002; (6):3-5. PubMed ID: 12592894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy with beta-blockers. Their effect on lipid metabolism].
    Honková M; Kotrlíková E; Mares P; Skorepa J
    Cas Lek Cesk; 1983 May; 122(20):614-7. PubMed ID: 6133623
    [No Abstract]   [Full Text] [Related]  

  • 5. Interactions between antihypertensive agents, serum lipids and cigarette smoking in high risk hypertensive patients.
    Plouin PF
    J Hum Hypertens; 1989 Dec; 3 Suppl 2():49-53; discussion 53-4. PubMed ID: 2575176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact on serum lipids of combinations of diuretics and beta-blockers and of beta-blockers alone.
    Helgeland A
    J Cardiovasc Pharmacol; 1984; 6 Suppl 3():S474-6. PubMed ID: 6208414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M; Richter WO; Schwandt P; Holzgreve H
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma lipids during chronic antihypertensive therapy with different beta-blockers.
    Fogari R; Zoppi A; Pasotti C; Poletti L; Tettamanti F; Malamani G; Corradi L
    J Cardiovasc Pharmacol; 1989; 14 Suppl 7():S28-32. PubMed ID: 2481787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blockers, dyslipidemia, and coronary artery disease. A reassessment.
    Burris JF
    Arch Intern Med; 1993 Sep; 153(18):2085-92. PubMed ID: 8104394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Beta blockers, fibrinogen, and atherosclerosis].
    Serrano Aguilar PG
    Med Clin (Barc); 1994 Feb; 102(6):231-5. PubMed ID: 7909001
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of bevantolol and propranolol on serum lipids in patients with essential hypertension.
    Sasaki J; Kajiyama G; Kusukawa R; Mori H; Koga S; Takagi R; Tanaka N; Ogawa N; Arakawa K
    Int J Clin Pharmacol Ther; 1994 Dec; 32(12):660-4. PubMed ID: 7881705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Which beta receptor blockers should be used in hypertension?].
    Werning C
    Fortschr Med; 1980 Feb; 98(5):157-60. PubMed ID: 6102958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of arotinolol on serum lipid and apolipoprotein levels in patients with mild essential hypertension.
    Sasaki J; Handa K; Arakawa K
    Clin Ther; 1989; 11(5):580-3. PubMed ID: 2478285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The editor's roundtable: revisiting the role of beta blockers in hypertension.
    Roberts WC; Black HR; Bakris GL; Mason RP; Giles TD; Sulkes DJ
    Am J Cardiol; 2007 Jul; 100(2):253-67. PubMed ID: 17631080
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes in plasma lipid levels after the administration of beta-adrenoblockaders: possible advantages of natural sympathomimetic activity].
    van Brummelen P
    Ter Arkh; 1986; 58(5):101-4. PubMed ID: 2874619
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of hypotensive agents on the lipid composition of the blood].
    Preobrazhenskiĭ DV; Sinitsyn VE
    Ter Arkh; 1985; 57(11):138-42. PubMed ID: 2867613
    [No Abstract]   [Full Text] [Related]  

  • 17. [Beta-receptor blockers: metabolic actions and therapeutic consequences (author's transl)].
    Lohmann FW
    MMW Munch Med Wochenschr; 1981 Nov; 123(47):1795-8. PubMed ID: 6118833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic changes during antihypertensive therapies.
    Krone W; Nägele H
    J Hum Hypertens; 1989 Dec; 3 Suppl 2():69-73; discussion 74. PubMed ID: 2575177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Do blood lipids go up when blood pressure goes down?].
    Rössner S
    Lakartidningen; 1978 Aug; 75(35):2943-4. PubMed ID: 29173
    [No Abstract]   [Full Text] [Related]  

  • 20. [Betaxolol treatment of hypertension in postmenopausal women].
    Bystrova MM; Britov AN; Gorbunov VM; Lebedev AV; Eliseeva NA; Metel'skaia VA
    Ter Arkh; 1999; 71(6):67-9. PubMed ID: 10420462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.